Detecting O-GlcNAc using in vitro sulfation

Glycobiology

Volumn 24, Issue 8, 2014, Pages 740-747

  Wu, Zhengliang L ^a   Robey, Matthew T ^a   Tatge, Timothy ^a   Lin, Cheng ^b   Leymarie, Nancy ^b   Zou, Yonglong ^a   Zaia, Joseph ^b  

^a R and D Systems Inc   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CHST; Glycosylation; O GlcNAc; OGA; OGT

Indexed keywords

CYTOPLASM PROTEIN; DODECYL SULFATE SODIUM; EPIDERMAL GROWTH FACTOR; GALACTOSYLTRANSFERASE; N ACETYLGLUCOSAMINE; NOTCH RECEPTOR; O LINKED BETA N ACETYLGLUCOSAMINE; SULFOTRANSFERASE; UNCLASSIFIED DRUG; ACETYLGLUCOSAMINIDASE; CARBOHYDRATE SULFOTRANSFERASES; SULFATE;

ARTICLE; AUTORADIOGRAPHY; ENZYME KINETICS; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SULFATION; GLYCOSYLATION; METABOLISM;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; GLYCOSYLATION; HEK293 CELLS; HUMANS; SULFATES; SULFOTRANSFERASES;

EID: 84903728715     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu037     Document Type: Article

References (34)

1. Clark PM, Dweck JF, Mason DE, Hart CR, Buck SB, Peters EC, Agnew BJ, Hsieh-Wilson LC. 2008. Direct iN-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteins. Journal of the American Chemical Society. 130: 11576-11577
2. Comer FI, Hart GW. 2001. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry. 40: 7845-7852. (Pubitemid 32622975
3. Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW. 2001. Characterization of a mouse monoclonal antibody specific for O-linked N-Acetylglucosamine. Analytical Biochemistry. 293: 169-177. (Pubitemid 32547901
4. Gao Y, Wells L, Comer FI, Parker GJ, Hart GW. 2001. Dynamic O-glycosylation of nuclear and cytosolic proteins: Cloning and characterization of a neutral, cytosolic beta-N-Acetylglucosaminidase from human brain. The Journal of Biological Chemistry. 276: 9838-9845
5. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. The Journal of General Virology. 36: 59-74
6. Gross BJ, Kraybill BC, Walker S. 2005. Discovery of O-GlcNAc transferase inhibitors. Journal of the American Chemical Society. 127: 14588-14589. (Pubitemid 41510995
7. Grunwell JR, Rath VL, Rasmussen J, Cabrilo Z, Bertozzi CR. 2002. Characterization and mutagenesis of Gal/GlcNAc-6-O-sulfotransferases. Biochemistry. 41: 15590-15600. (Pubitemid 36062463
8. Haltiwanger RS, Holt GD, Hart GW. 1990. Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-Acetylglucosamine: Peptide beta-N-Acetylglucosaminyltransferase. The Journal of Biological Chemistry. 265: 2563-2568
9. Hart GW, Housley MP, Slawson C. 2007. Cycling of O-linked beta-N-Acetylglucosamine on nucleocytoplasmic proteins. Nature. 446: 1017-1022. (Pubitemid 46676063
10. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. 2011. Cross talk between O-GlcNAcylation and phosphorylation: Roles in signaling, transcription, and chronic disease. Annual Review of Biochemistry. 80: 825-858
11. Holt GD, Hart GW. 1986. The subcellular distribution of terminal N-Acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. The Journal of Biological Chemistry. 261: 8049-8057. (Pubitemid 17208742
12. Isono T. 2011. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation. PLoS One. 6: E18959
13. Khidekel N, Arndt S, Lamarre-Vincent N, Lippert A, Poulin-Kerstien KG, Ramakrishnan B, Qasba PK, Hsieh-Wilson LC. 2003. A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications. Journal of the American Chemical Society. 125: 16162-16163. (Pubitemid 38020622
14. Li S, Zhang L, Yao Q, Li L, Dong N, Rong J, Gao W, Ding X, Sun L, Chen X, et al. 2013. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature. 501: 242-246
15. Love DC, Hanover JA. 2005. The hexosamine signaling pathway: Deciphering the O-GlcNAc code. Science's STKE: Signal Transduction Knowledge Environment. 2005: Re13
16. Ma J, Hart GW. 2013. Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Review of Proteomics. 10: 365-380
17. Ma Z, Vosseller K. 2013. O-GlcNAc in cancer biology. Amino Acids. 45: 719-733
18. Matsuura A, Ito M, Sakaidani Y, Kondo T, Murakami K, Furukawa K, Nadano D, Matsuda T, Okajima T. 2008. O-linked N-Acetylglucosamine is present on the extracellular domain of notch receptors. The Journal of Biological Chemistry. 283: 35486-35495
19. Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TW, Mansell A, Riedmaier P, Oates CV, et al. 2013. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature. 501: 247-251
20. Prather B, Ethen CM, Machacek M, Wu ZL. 2012. Golgi-resident PAP-specific 3′-phosphatase-coupled sulfotransferase assays. Analytical Biochemistry. 423: 86-92
21. Ramakrishnan B, Qasba PK. 2002. Structure-based design of beta 1, 4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-Acetylgalactosaminyltransferase activity: Point mutation broadens beta 4Gal-T1 donor specificity. The Journal of Biological Chemistry. 277: 20833-20839. (Pubitemid 34967390
22. Roquemore EP, Chou TY, Hart GW. 1994. Detection of O-linked N-Acetylglucosamine (O-GlcNAc) on cytoplasmic and nuclear proteins. Methods in Enzymology. 230: 443-460
23. Sakaidani Y, Ichiyanagi N, Saito C, Nomura T, Ito M, Nishio Y, Nadano D, Matsuda T, Furukawa K, Okajima T. 2012. O-linked-N-Acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1. Biochemical and Biophysical Research Communications. 419: 14-19
24. Slawson C, Housley MP, Hart GW. 2006. O-GlcNAc cycling: How a single sugar post-Translational modification is changing the way we think about signaling networks. Journal of Cellular Biochemistry. 97: 71-83. (Pubitemid 43050180
25. Snow CM, Senior A, Gerace L. 1987. Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. The Journal of Cell Biology. 104: 1143-1156. (Pubitemid 17084472
26. Tashima Y, Stanley P. 2014. Antibodies that detect O-GlcNAc on the extracellular domain of cell surface glycoproteins. The Journal of Biological Chemistry. 289: 11132-11142
27. Teo CF, Ingale S, Wolfert MA, Elsayed GA, Not LG, Chatham JC, Wells L, Boons GJ. 2010. Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc. Nature Chemical Biology. 6: 338-343
28. Torres CR, Hart GW. 1984. Topography and polypeptide distribution of terminal N-Acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. The Journal of Biological Chemistry. 259: 3308-3317. (Pubitemid 14130544
29. Trinidad JC, Barkan DT, Gulledge BF, Thalhammer A, Sali A, Schoepfer R, Burlingame AL. 2012. Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Molecular & Cellular Proteomics: MCP. 11: 215-229
30. Uchimura K, El-Fasakhany FM, Hori M, Hemmerich S, Blink SE, Kansas GS, Kanamori A, Kumamoto K, Kannagi R, Muramatsu T. 2002. Specificities of N-Acetylglucosamine-6-O-sulfotransferases in relation to L-selectin ligand synthesis and tumor-Associated enzyme expression. The Journal of Biological Chemistry. 277: 3979-3984. (Pubitemid 34968652
31. Wu ZL, Ethen CM, Larson S, Prather B, Jiang W. 2010. Aversatile polyacrylamide gel electrophoresis based sulfotransferase assay. BMC Biotechnology. 10: 11
32. Wu ZL, Lech M. 2005. Modification degrees at specific sites on heparan sulphate: An approach to measure chemical modifications on biological molecules with stable isotope labelling. The Biochemical Journal. 389: 383-388
33. Wu ZL, Prather B, Ethen CM, Kalyuzhny A, Jiang W. 2011. Detection of specific glycosaminoglycans and glycan epitopes by in vitro sulfation using recombinant sulfotransferases. Glycobiology. 21: 625-633
34. Wu ZL, Zhang L, Beeler DL, Kuberan B, Rosenberg RD. 2002. A new strategy for defining critical functional groups on heparan sulfate. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 16: 539-545. (Pubitemid 34273237.